Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-062196
Filing Date
2011-11-08
Accepted
2011-11-08 17:01:27
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25003_110q.htm 10-Q 1503555
2 EX-31.1 a11-25003_1ex31d1.htm EX-31.1 11327
3 EX-32.1 a11-25003_1ex32d1.htm EX-32.1 6958
  Complete submission text file 0001104659-11-062196.txt   8734972

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT amag-20110930.xml EX-101.INS 1510448
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20110930.xsd EX-101.SCH 52773
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20110930_cal.xml EX-101.CAL 60252
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT amag-20110930_lab.xml EX-101.LAB 760016
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20110930_pre.xml EX-101.PRE 359042
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20110930_def.xml EX-101.DEF 255883
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

EIN.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 111188515
SIC: 2834 Pharmaceutical Preparations